Sanofi and Merck Announce Animal Health Venture
Merck and Sanofi-Aventis, two of the world's biggest pharmaceutical companies, said Tuesday they are uniting their animal health businesses in a deal to lead in the veterinary industry, The Associated...
View ArticleHesitation on Wall Street Leaves Shares Flat
Lacking a clear consensus about the strength of the recovery, Wall Street fell into a seesaw pattern on Monday.
View ArticleDoes Merck Agreement Pave a Road Toward Change?
The settlement by Merck of a shareholder lawsuit over Vioxx represent what may turn out to be a pivotal moment in the corporate governance arena.
View ArticleRoche Profit Up on Genentech Synergies
A little more than a year after acquiring Genentech, Roche said Thursday that its profits for the first half of this year had risen by 37 percent from the same period a year before as exceptional costs...
View ArticleBeware of the F.T.C.
The Federal Trade Commission has been taking a tougher line to make sure that mergers do not produce monopolies.
View ArticleSanofi Raising $7 Billion in Debt to Fund Genzyme Deal
The French pharmaceutical giant Sanofi-Aventis says it will issue $7 billion worth of notes to help finance its acquisition of the American biotechnology firm Genzyme.
View ArticleTax Policy Change Would Bring Cash Piles Abroad Back Home
JPMorgan Chase estimated that 519 American multinational corporations had $1.37 trillion outside the United States. The Deal Professor offers a way to repatriate some of that money.
View ArticleRanking Google’s Hefty Motorola Breakup Fee
At $2.5 billion, Google's breakup fee ranks among the five largest since 2000, according to data from Thomson Reuters.
View ArticleAhead of Facebook I.P.O., a Skeptical Madison Ave.
Despite the overwhelming level of interest in its I.P.O., Facebook is facing fresh concerns over its ability to attract enough advertising revenue. Will the social network reach its advertising potential?
View ArticleRoche Profit Up on Genentech Synergies
A little more than a year after acquiring Genentech, Roche said Thursday that its profits for the first half of this year had risen by 37 percent from the same period a year before as exceptional costs...
View ArticleBeware of the F.T.C.
The Federal Trade Commission has been taking a tougher line to make sure that mergers do not produce monopolies.
View ArticleSanofi Raising $7 Billion in Debt to Fund Genzyme Deal
The French pharmaceutical giant Sanofi-Aventis says it will issue $7 billion worth of notes to help finance its acquisition of the American biotechnology firm Genzyme.
View ArticleTax Policy Change Would Bring Cash Piles Abroad Back Home
JPMorgan Chase estimated that 519 American multinational corporations had $1.37 trillion outside the United States. The Deal Professor offers a way to repatriate some of that money.
View ArticleRanking Google’s Hefty Motorola Breakup Fee
At $2.5 billion, Google's breakup fee ranks among the five largest since 2000, according to data from Thomson Reuters.
View ArticleAhead of Facebook I.P.O., a Skeptical Madison Ave.
Despite the overwhelming level of interest in its I.P.O., Facebook is facing fresh concerns over its ability to attract enough advertising revenue. Will the social network reach its advertising potential?
View Article
